This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Sarepta Therapeutics Inc
SRPT : NASDAQ : Health Care
$13.21 | %
Today's Range: 13.19 - 13.76
Avg. Daily Volume: 1,738,500
12/19/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
SRPT SAREPTA THERAPEUTICS INC 14.30 590.73 n/m 12.36 -34.73
ARRY ARRAY BIOPHARMA INC 4.90 646.62 n/m 33.92 -50.11
LXRX LEXICON PHARMACEUTICALS INC 0.90 642.46 n/m 2.78 170.09
FMI FOUNDATION MEDICINE INC 21.83 618.03 n/m 52.06 534.27
AEGR AEGERION PHARMACEUTICALS INC 21.31 605.97 n/m 131.16 445.32
OMED ONCOMED PHARMACEUTICALS 20.19 602.31 n/m 50.03 94.46
XOMA XOMA CORP 4.70 542.71 n/m 27.05 -10.75
RPTP RAPTOR PHARMACEUTICAL CORP 8.22 522.50 n/m 62.46 842.91
GERN GERON CORP 3.23 507.79 n/m 1.20 -31.32
PRTA PROTHENA CORP PLC 18.49 506.33 n/m 49.01 4421.03
VNDA VANDA PHARMACEUTICALS INC 12.89 501.43 n/m 43.57 31.96
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

SRPT Ind Avg S&P 500
n/m 66.62 19.74

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs